JP2024521209A5 - - Google Patents

Info

Publication number
JP2024521209A5
JP2024521209A5 JP2023574125A JP2023574125A JP2024521209A5 JP 2024521209 A5 JP2024521209 A5 JP 2024521209A5 JP 2023574125 A JP2023574125 A JP 2023574125A JP 2023574125 A JP2023574125 A JP 2023574125A JP 2024521209 A5 JP2024521209 A5 JP 2024521209A5
Authority
JP
Japan
Prior art keywords
negatively charged
substituted
compound
complex
ceremony
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023574125A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024521209A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2022/055214 external-priority patent/WO2022254405A1/en
Publication of JP2024521209A publication Critical patent/JP2024521209A/ja
Publication of JP2024521209A5 publication Critical patent/JP2024521209A5/ja
Pending legal-status Critical Current

Links

JP2023574125A 2021-06-04 2022-06-03 ｓｉＲＮＡ送達ベクター Pending JP2024521209A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN202111024926 2021-06-04
IN202111024926 2021-06-04
PCT/IB2022/055214 WO2022254405A1 (en) 2021-06-04 2022-06-03 siRNA DELIVERY VECTOR

Publications (2)

Publication Number Publication Date
JP2024521209A JP2024521209A (ja) 2024-05-28
JP2024521209A5 true JP2024521209A5 (cg-RX-API-DMAC7.html) 2025-06-11

Family

ID=82558096

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023574125A Pending JP2024521209A (ja) 2021-06-04 2022-06-03 ｓｉＲＮＡ送達ベクター

Country Status (8)

Country Link
US (1) US20240277851A1 (cg-RX-API-DMAC7.html)
EP (1) EP4346902A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024521209A (cg-RX-API-DMAC7.html)
CN (1) CN117396227A (cg-RX-API-DMAC7.html)
AU (1) AU2022287326A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023025242A2 (cg-RX-API-DMAC7.html)
CA (1) CA3220535A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022254405A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116159145B (zh) * 2023-01-31 2025-04-22 四川大学 含七叶皂苷和/或其盐化合物的转染复合物在促转染的应用
CN120617243A (zh) * 2024-11-15 2025-09-12 江苏省肿瘤医院 瑞香素作为抑制剂在制备治疗三阴性乳腺癌的药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2540234B (en) * 2015-02-19 2020-12-02 Council Scient Ind Res An antioxidant compound having anti atherosclerotic effect and preparation thereof
US11213960B2 (en) 2018-09-17 2022-01-04 John AMBIELLI Multi-tool and storage device
AR127082A1 (es) * 2019-11-22 2023-12-20 Council Scient Ind Res Compuestos antiinflamatorios para el tratamiento de trastornos cutáneos

Similar Documents

Publication Publication Date Title
JP7326622B2 (ja) Ｅｒｋ阻害剤としてのスピロ系化合物およびその使用
JP2024521209A5 (cg-RX-API-DMAC7.html)
AU2009308511B2 (en) Transition metal complexes of a bis[thiohydrazide amide] compound
JP2021532162A5 (cg-RX-API-DMAC7.html)
JP2015512413A5 (cg-RX-API-DMAC7.html)
JP7520366B2 (ja) 腫瘍療法の副作用の予防または治療方法
US12472187B2 (en) Texaphyrin-Pt(IV) conjugates and compositions for use in overcoming platinum resistance
JP2014510774A5 (cg-RX-API-DMAC7.html)
JP2021515083A5 (cg-RX-API-DMAC7.html)
JP2011523643A5 (cg-RX-API-DMAC7.html)
JP2006511534A5 (cg-RX-API-DMAC7.html)
JP2015520143A5 (cg-RX-API-DMAC7.html)
JP2008505157A5 (cg-RX-API-DMAC7.html)
JP2023532128A5 (cg-RX-API-DMAC7.html)
JP2002525329A5 (cg-RX-API-DMAC7.html)
JP5149177B2 (ja) 増殖性疾患の治療のための、チューブリンポリマー化の１，２，３−トリアゾール系抑制剤
JP2009544676A5 (cg-RX-API-DMAC7.html)
JP2018531987A5 (cg-RX-API-DMAC7.html)
JP2023538524A5 (cg-RX-API-DMAC7.html)
JP2010528122A5 (cg-RX-API-DMAC7.html)
JP2007505044A5 (cg-RX-API-DMAC7.html)
US6255495B1 (en) Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups and method of application thereof
RU2005138366A (ru) Производные бензимидазола, композиции, содержащие их, их получение и их применение
JP2024538730A5 (cg-RX-API-DMAC7.html)
EP2321323B1 (fr) Derives dimeriques d'artemisinine et application en therapie anticancereuse